The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Activity of single-agent gemcitabine in patients (pts) with advanced angiosarcoma: A retrospective study.
 
SARAH WATSON
No Relationships to Disclose
 
Benjamin Verret
No Relationships to Disclose
 
Stanislas Ropert
Consulting or Advisory Role - Bayer; Novartis; Sanofi
 
Julien Adam
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche
Research Funding - Merck Sharp & Dohme (Inst); Pierre Fabre (Inst)
 
Rastilav Bahleda
No Relationships to Disclose
 
Sylvain Briand
No Relationships to Disclose
 
Andrea Cavalcanti
No Relationships to Disclose
 
Ali N. Chamseddine
No Relationships to Disclose
 
Charles Court
Stock and Other Ownership Interests - NeuroFrance; SpineGuard
Consulting or Advisory Role - Medtronic; Safe Orthopaedics
 
Elie Fadel
No Relationships to Disclose
 
Matthieu Faron
Honoraria - Novartis (Inst)
Consulting or Advisory Role - HRA Pharma
Travel, Accommodations, Expenses - Ipsen; Novartis; Pfizer
 
Leila Haddag
No Relationships to Disclose
 
Clemence Henon
No Relationships to Disclose
 
Cecile Le Pechoux
Honoraria - Lilly (Inst); Medscape (Inst); Prime Oncology
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Nanobiotix (Inst); Roche (Inst)
 
Antonin Levy
No Relationships to Disclose
 
Olaf Mercier
Consulting or Advisory Role - AstraZeneca
 
Carine Ngo
No Relationships to Disclose
 
Charles Honoré
No Relationships to Disclose
 
Axel Le Cesne
Honoraria - Bayer; PharmaMar
 
Olivier Mir
Stock and Other Ownership Interests - Amplitude Surgical; Ipsen; Transgene
Honoraria - Roche
Consulting or Advisory Role - Janssen; Lilly; Lundbeck; Pfizer; Roche
Speakers' Bureau - Lilly; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Blueprint Medicines (Inst); Ipsen
Travel, Accommodations, Expenses - Pfizer; Roche